Physician profile
Christopher Antonio Brown
NPI 1598728628
$2,327.92
in general payments reported to CMS, 2019-2025
14 companies · $75.13 in 2025
The $75.13 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $47.56 · 2021: $278 · 2022: $646 · 2023: $220 · 2024: $898 · 2025: $75.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $675 · Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $674.54 |
| Food and Beverage | $519.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $1,182.14 | 2022-2024 | Safeop |
| Horizon Therapeutics Plc | $378.34 | 2019-2022 | |
| Becton, Dickinson and Company | $201.43 | 2023 | Phasix Mesh |
| Verity Pharmaceuticals INC. | $190.65 | 2023-2025 | Trelstar, Tlando |
| Biotronik INC. | $133.04 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $59.12 | 2025 | |
| Surgalign Spine Technologies, INC. | $43.87 | 2019 | |
| Amgen INC. | $30.78 | 2024 | Krystexxa |
| Bioventus LLC | $28.17 | 2020-2022 | |
| Abbott Laboratories | $20.66 | 2024 | Proclaim |
| Globus Medical, INC. | $16.64 | 2024 | Coalition Agx / Agx Rp, Acp |
| Medtronic USA, INC. | $14.98 | 2020 | |
| Depuy Synthes Sales INC. | $14.09 | 2022 | |
| Bausch & Lomb Americas INC. | $14.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.